Glaucoma y miopía agudos inducidos por el uso de topiramato

Julio Torales Benitez; Enrique De Doménico Meyer; Eliana Duarte Fariña

doi:10.18004/anales/2019.052(02)35-038

Authors

Julio Torales Benitez Universidad Nacional de Asunción, Facultad de Ciencias Médicas, Cátedra de Psiquiatría. Asunción, Paraguay.
Enrique De Doménico Meyer Universidad Nacional de Asunción, Facultad de Ciencias Médicas, Cátedra de Psiquiatría. Asunción, Paraguay.
Eliana Duarte Fariña Universidad Nacional de Asunción, Facultad de Ciencias Médicas, Cátedra de Oftalmología. Asunción, Paraguay.

DOI:

https://doi.org/10.18004/anales/2019.052(02)35-038

Keywords:

Topiramate, Myopia, Glaucoma by secondary angular closure, Paraguay

Abstract

Topiramate is a drug used in several diseases, such as neurological and psychiatric ones. Among its adverse effects are the production of acute myopia and glaucoma by secondary angular closure in previously healthy eyes. Although these are relatively infrequent adverse effects, they must be taken into consideration since their clinical expression (headache and periocular pain, among others) can often be confused with the pathology for which topiramate was being used (for example, for the treatment of migraine). The foregoing is important since such adverse effects will only cease with the interruption of the use of the drug. In this brief review article, we present basic concepts about the physiopathology and treatment of myopia and glaucoma by angular closure induced by the use of topiramate.

References

1. Rudkin AK, Gray TL, Awadalla M, Craig JE. Bilateralsimultaneous acute angle closure glaucoma precipitatedby non-prescription cold and flu medication. Emerg MedAustralas. 2010;22(5):477-479. https://doi.org/10.1111/j.1742-6723.2010.01338.x

2. Razeghinejad MR, Pro MJ, Katz LJ. Non-steroidal drug-induced glaucoma. Eye (Lond). 2011;25(8):971-980.https://doi.org/10.1038/eye.2011.128

3. Islam MN. Bilateral Acute Angle Closure from Topiramatetoxicity – 3 case reports. Journal Bangladesh GlaucomaSociety 2018;6(2):43-46.

4. Banta JT, Hoffman K, Budenz DL, Ceballos E, GreenfieldDS. Presumed Topiramate-induced Bilateral Acute Angle-closure Glaucoma. Am J Ophthalmol. 2001;132(1):112-114. https://doi.org/10.1016/S0002-9394(01)01013-3

5. Lin CC, Tseng PC, Chen CC, Woung LC, Liou SW.Topiramate-induced bilateral secondary angle closure and myopia shift. Taiwan Journal of Ophthalmology 2014;4(1):45-48.

6. Sankar PS, Pasquale LR, Grosskreutz CL. Uveal effusionand secondary angle-closure glaucoma associated with topiramate use. Arch Ophthalmol. 2001;119(8):1210-1211.

7. Thambi L, Kapcala L, Chambers W. Topiramate-Associated Secondary Angle-Closure Glaucoma: A Case Series. Arch Ophthalmol. 2002;120(8):1108. https://doi.org/10.1001/archopht.120.8.1108

8. Chalam, KV, Tillis T, Syed F, Agarwal S, Brar V. Acutebilateral simultaneous angle closure glaucoma after topiramate administration: a case report. Journal of Medical Case Reports 2008;2:1. https://doi.org/10.1186/1752-1947-2-1

9. Silberstein SD: Topiramate Chronic Migraine Study Group.Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache. 2007;47(2):170-180. https://doi.org/10.1111/j.1526-4610.2006.00684

10. Stahl SM. Stahl’s Essential Psychopharmacology:Prescriber’s Guide. 5th ed. New York: Cambridge University Press; 2014.

11. Eisenberg E, River Y, Shifrin A, Krivoy N. Antiepilepticdrugs in the treatment of neuropathic pain. Drugs. 2007;67(9):1265-1289. https://doi.org/10.2165/00003495-200767090-00003

12. Raskin P, Donofrio PD, Rosenthal NR, Hewitt DJ, JordanDM, Xiang J et al. Topiramate vs placebo in painful diabetic neuropathy: analgesic and metabolic effects. Neurology. 2004;63(5): 865-873.

13. Celebisoy N, Gökcay F, Sirin H, Akyûrekli O. Treatmentof idiopathic intracranial hypertension: topiramate vs acetazolamide, on open-label study. Acta Neurol Scand. 2007;116(5):322-327. https://doi.org/10.1111/j.1600-0404.2007.00905.x

14. Johnson BA, Rosenthal N, Capece JA, Wiegand F, Mao L,Beyers K et al. Topiramate for treating alcohol dependence: a randomized control trial. JAMA. 2007;298(14): 1641-1651. https://doi.org/10.1001/jama.298.14.1641

15. Johnson BA, Ait-Daoud N, Akhtar FZ, Javors MA. Use oforal topiramate to promote smoking abstinence among alcohol-dependent smokers: a randomized control trial. Arch Intern Med. 2005;165(14):1600-1605 https://doi.org/10.1001/archinte.165.14.1600

16. Torales J, Arce A, Zacarías M, Girala N, Moreno M, Szwako A et al. La Guía TAZ de Psicofarmacología Clínica. 1ª ed. Asunción: EFACIM; 2014.

17. Santos-Nevarez V, Cantrell J, Gruosso P, Miller J, Culotta-Glynn T. Topiramate-Induced Acute Bilateral Angle Closure Glaucoma and Transient Myopia: A Teaching Case Report. Optometric Education 2015;40(3):3-10.

18. Levy J, Yagev R, Petrova A, Lifshitz T. Topiramate-inducedbilateral angle-closure glaucoma. Can J Ophthalmol2006;41(2):221-225. https://doi.org/10.1139/I06-012

19. Fraunfelder FW, Fraunfelder FT, Keates EU. Topiramate-Associated Acute, Bilateral, Secondary Angle-ClosureGlaucoma. Ophthalmology 2004, 111(1):109-111. https://doi.org/10.1016/j.ophtha.2003.04.004

20. Craig JE, Ong TJ, Louis DL, Wells JM. Mechanism ofTopiramate-induced Acute-onset Myopia and Angle Closure Glaucoma. Am J Ophthalmol. 2004;137(1):193-195. https://doi.org/10.1016/S0002-9394(03)00774-8

21. Medeiros FA, Zhang XY, Bernd AS, Weinreb RN.Angle-Closure Glaucoma Associated With CiliaryBody Detachment in Patients Using Topiramate. ArchOphthalmol. 2003;121(2):282-285.

22. Krieg PHSchipper I Drug-induced ciliary body oedema: anew theory. Eye (Lond). 1996;10(Pt 1):121-126. https://doi.org/10.1038/eye.1996.21

23. Sbeity Z, Gvozdyuk N, Amde W, Liebmann JM, Ritch R.Argon laser peripheral iridoplasty for topiramate-inducedbilateral acute angle closure. J Glaucoma. 2009;18(4):269-271. https://doi.org/10.1097/IJG.0b013e31818159e9